Gefitinib TabletsGefitinib tablets, known by brand names like IRESSA 250mg and ZEFOTIB, are crucial in treating non-small cell lung cancer (NSCLC). As a tyrosine kinase inhibitor, gefitinib targets specific mutations like EGFR, hindering cancer cell growth and spread. Its usage benefits patients by extending survival rates, alleviating symptoms, and enhancing overall quality of life. Common effects include improved breathing and reduced tumor size. However, side-effects such as diarrhea, skin rash, and liver toxicity may occur. Despite these risks, Gefitinib tablets represent a significant advancement in NSCLC treatment, offering targeted therapy options with the potential for prolonged remission and improved prognosis.
|
|
MODERN TIMES HELP LINES PHARMA
All Rights Reserved.(Terms of Use) Developed and Managed by Infocom Network Private Limited. |